CPR GPW Periodic report · PAP Biznes
Compremum SA (CPR) · Q1 2026 results
Share price: 1.15 zł · 2026-11-10
Results Q1 2026 vs Q1 2025 · year over year · published 29 May 2026 and 30 May 2025
EPS turned to a profit from a loss a year earlier. The report's language is unchanged.
Only a basic analysis is available for this company at the moment.
1 · Numbers
Turned profit
EPS vs Q1 2025
EPS 0.21 vs -0.26
2 · How the report reads
Unchanged
Language tone vs last period
Report language: restrained for a company report — about as upbeat as in Q1 2025.
Weak signal: formal report language, not a call.
3 · What stood out
Figure
The company announced PLN 172.6 billion in funding, of which PLN 82.3 billion is allocated for the years 2026-2030.
Read between the lines
-
Key theme
The issuer issued blank promissory notes as collateral for potential claims from financial institutions regarding granted credit lines.
Source quote
“On the balance sheet date, the Issuer issued its own blank promissory notes serving as security for potential claims of financial institutions regarding credit limits granted to the Company.”
Tone
How upbeat the language was, compared with other companiesiTone counts positive minus negative finance words, adjusted for length. Executives mostly speak positively, so the labels compare each call with every company's latest call: “typical” is the middle third, “very upbeat” the top tenth, “cautious” the bottom tenth.. Dot: Q1 2026. Ring: Q1 2025.
Restrained for a company report — about as upbeat as in Q1 2025. Periodic reports carry legally required risk wording, so their tone moves little and is a weak signal.
Sentences that drove the tone
“Credit risk is the risk of the Group incurring losses due to the failure of a customer or a counterparty of the Group, who is a party to a contract, to fulfill its contractual obligations.”
“PLN, which represents an improvement in the result and a reduction in the loss by 1,427 thousand.”
Full figures
PLN · PAP Biznes report (2026-05-29)
| Metric | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | 15.0M | — | |
| Operating income | 4.8M | — | |
| EPS | 0.21 | -0.26 | Turned profit |
| P/E | 12-mo loss | 12-mo loss | — |
Topics
Topics are drawn from the full report text, not management commentary.
Most discussed now
- The Issuer or an entity of the Group, when submitting offers or entering into agreements for the performance of services within its…
- Boards, who provide the opportunity to obtain financing both through the involvement of external entities (industry specialists or strictly…
- During the reporting period, the Group generated sales revenue of 15,015 thousand.
Faded since Q1 2025
- Fading The Issuer also confirms that as of the date of approval of the quarterly consolidated financial statements for publication, the Group does…
- Fading The Company's and the Group's exposure to interest rate risk arises primarily from debt obligations, cash and cash equivalents, and loans…
- Fading The issuer is exposed to interest rate risk primarily in connection with financial lease agreements and loan agreements.
- Fading The value of the liability secured by the aforementioned guarantees amounted to 5,999 thousand as of the balance sheet date.
Latest announcements
Official filings, newest first.
- Half-year report · ESPI periodic
- Uzupełnienie raportu finansowego Spółki za I półrocze 2026 r. · ESPI 12/2026
- Half-year report · ESPI periodic
- Zarejestrowanie zmian Statutu Spółki. · ESPI 11/2026
- Wybór podmiotu uprawnionego do przeglądu i badania sprawozdań finansowych Spółki i Grupy Kapitałowej. · ESPI 10/2026
- Informacje dotyczące Zwyczajnego Walnego Zgromadzenia z dnia 26 czerwca 2026 roku · ESPI 9/2026
- Quarterly report · ESPI periodic
- Ogłoszenie o zwołaniu Zwyczajnego Walnego Zgromadzenia Spółki. · ESPI 8/2026